Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
The Journal of Pharmacy and Pharmacology|July 16, 2019
Advancements in nanotherapeutics for Alzheimer's disease: current perspectivesSeetha Harilal, Jobin Jose, Della Grace Thomas Parambi, et al.
Archiv Der Pharmazie|May 22, 2024
A literature review on pharmacological aspects, docking studies, and synthetic approaches of quinazoline and quinazolinone derivativesMohammed M Ghoneim, Mohamed A Abdelgawad, Nadia A A Elkanzi, et al.
RSC Advances|March 6, 2026
Morpholine as a privileged scaffold for neurodegenerative disease therapeuticsSaranya Kattil Parmbil, Sunil Kumar, T M Rangarajan, et al.
European Journal of Medicinal Chemistry|August 18, 2019
Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart workRajesh Kumar, Seetha Harilal, Sheeba Varghese Gupta, et al.
Environmental Science and Pollution Research International|March 20, 2021
Piperazine-substituted chalcones: a new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disordersBijo Mathew, Jong Min Oh, Roua S Baty, et al.
Bioorganic Chemistry|October 14, 2019
Design, synthesis and biological evaluation of oxygenated chalcones as potent and selective MAO-B inhibitorsDella Grace Thomas Parambi, Jong Min Oh, Seung Cheol Baek, et al.
Current Neuropharmacology|September 10, 2021
The Role of Mitochondrial Genes in Neurodegenerative DisordersRajesh Kumar, Seetha Harilal, Della Grace Thomas Parambi, et al.
The Journal of Physical Chemistry. A|May 17, 2011
A single chiroptical spectroscopic method may not be able to establish the absolute configurations of diastereomers: dimethylesters of hibiscus and garcinia acidsPrasad L Polavarapu, Emily A Donahue, Ganesh Shanmugam, et al.
RSC Advances|September 3, 2024
FDA-approved drugs containing dimethylamine pharmacophore: a review of the last 50 yearsSandeep Bindra, Kuntal Bose, Amrutha Chandran Thekkantavida, et al.
Pageof 7